Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events - Archive ouverte HAL Access content directly
Journal Articles Molecular Informatics Year : 2020

Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events

Abstract

Adverse drug reactions (ADRs) are of major concern in drug safety. However, due to the biological complexity of human systems, understanding the underlying mechanisms involved in development of ADRs remains a challenging task. Here, we applied network sciences to analyze a tripartite network between 1000 drugs, 1407 targets, and 6164 ADRs. It allowed us to suggest drug targets susceptible to be associated to ADRs and organs, based on the system organ class (SOC). Furthermore, a score was developed to determine the contribution of a set of proteins to ADRs. Finally, we identified proteins that might increase the susceptibility of genes to ADRs, on the basis of knowledge about genomic structural variation in genes encoding proteins targeted by drugs. Such analysis should pave the way to individualize drug therapy and precision medicine.
Fichier principal
Vignette du fichier
MINF-39-2000116.pdf (3.51 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03300415 , version 1 (15-11-2022)

Identifiers

Cite

Bryan Dafniet, Natacha Cerisier, Karine Audouze, Olivier Taboureau. Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events. Molecular Informatics, 2020, 39 (12), ⟨10.1002/minf.202000116⟩. ⟨hal-03300415⟩
27 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More